Actively Recruiting
Study Comparing Sugammadex, Neostigmine, and No Medication to Speed Neurological Assessment After Intubation in Critically Ill Adults
Led by Seoul National University Hospital · Updated on 2026-06-02
30
Participants Needed
1
Research Sites
34 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to compare how different reversal agents for neuromuscular blockade affect the time needed for neurological assessment after endotracheal intubation in critically ill patients. The study evaluates whether using these agents can shorten the wait before assessing neurological function and whether different agents have varying effects. Participants are adults admitted to intensive care who require intubation and sedation with etomidate and rocuronium. Participants are randomly assigned to one of three groups receiving sugammadex, neostigmine with glycopyrrolate, or no reversal medication control. Thirty minutes after rocuronium administration, the assigned medication is given if applicable. Neurological assessments using the Glasgow Coma Scale GCS are conducted frequently before and after medication administration. Continuous monitoring includes processed EEG and cerebral oxygen saturation, and neuromuscular function is tracked every five minutes starting 30 minutes after rocuronium dosing. During the study, neurological responses such as eye opening and motor function are assessed repeatedly up to 48 hours or until the patient responds adequately. Researchers record times to first neurological assessments and spontaneous eye opening. Secondary outcomes include changes in brain activity indices, oxygen saturation, timing of extubation, length of hospital and ICU stays, and mortality rates within one month. The total participation period varies depending on patient recovery and monitoring needs.
CONDITIONS
Brief Title
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
Research Team
L
Leerang Lim, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here